ORGANOGENESIS INC.

History

YearDetail
1985 Organogenesis Inc. was founded in 1985. The company was spun off from regenerative technology developed at the Massachusetts Institute of Technology (MIT).
2014 Organogenesis Inc. acquired Dermagraft assets, a human fibroblast-derived dermal substitute, from Shire plc to treat chronic diabetic foot ulcers.
2017 Organogenesis acquired NuTech Medical, a developer of amniotic biologic products, and expanded its product portfolio to include surgical and sports medicine.
AI Sentiment